Sex differences in the non-linear association between BMI and LDL cholesterol in type 2 diabetes.
BMI
LDL-C
generalized additive models
sex differences
type 2 diabetes mellitus
Journal
Frontiers in endocrinology
ISSN: 1664-2392
Titre abrégé: Front Endocrinol (Lausanne)
Pays: Switzerland
ID NLM: 101555782
Informations de publication
Date de publication:
2023
2023
Historique:
received:
05
03
2023
accepted:
26
06
2023
medline:
25
7
2023
pubmed:
24
7
2023
entrez:
24
7
2023
Statut:
epublish
Résumé
A data-based study reported the linear relationship between body mass index (BMI) and low-density lipoprotein cholesterol (LDL-C) in a normal population. However, there were no studies giving the suggestion for diabetes patients limited by sample size. This study aimed to investigate the non-linear dose-response relationship between BMI and LDL-C in type 2 diabetes mellitus (T2DM). The study participants registered at the National Metabolic Management Center (MMC) of Beijing Luhe hospital from June 2017 to June 2021. T2DM was diagnosed according to the 1999 World Organization criteria. The generalized additive models (GAMs) were used to investigate the non-linear association between BMI and LDL-C. The relationship between BMI and LDL-C was visualized via the smooth splines function plot by sex. Segmented regressions were fitted to calculate the slopes with different estimated breakpoints. After data cleaning, a total of 2500 participants with T2DM aged 30 to 70 years were included in this study. Compared with females, the spline between BMI and LDL-C showed an Inverted U shape in males. In males, the slopes below and above the breakpoint (26.08. 95% CI: 24.13 to 28.03) were 2.38 (95%CI: 1.06, 3.70) and -0.36 (95%CI: -1.20, 0.48), respectively. There was an Inverted U shape association between BMI and LDL-C in male participants with T2DM, for which the LDL-C was increased with BMI in the lean population, while LDL-C gradually tended to be flat or even decreased in the obese population. However, the Inverted U-shape between BMI and LDL-C was not found in female patients with T2DM.
Sections du résumé
Background
A data-based study reported the linear relationship between body mass index (BMI) and low-density lipoprotein cholesterol (LDL-C) in a normal population. However, there were no studies giving the suggestion for diabetes patients limited by sample size. This study aimed to investigate the non-linear dose-response relationship between BMI and LDL-C in type 2 diabetes mellitus (T2DM).
Method
The study participants registered at the National Metabolic Management Center (MMC) of Beijing Luhe hospital from June 2017 to June 2021. T2DM was diagnosed according to the 1999 World Organization criteria. The generalized additive models (GAMs) were used to investigate the non-linear association between BMI and LDL-C. The relationship between BMI and LDL-C was visualized via the smooth splines function plot by sex. Segmented regressions were fitted to calculate the slopes with different estimated breakpoints.
Results
After data cleaning, a total of 2500 participants with T2DM aged 30 to 70 years were included in this study. Compared with females, the spline between BMI and LDL-C showed an Inverted U shape in males. In males, the slopes below and above the breakpoint (26.08. 95% CI: 24.13 to 28.03) were 2.38 (95%CI: 1.06, 3.70) and -0.36 (95%CI: -1.20, 0.48), respectively.
Conclusion
There was an Inverted U shape association between BMI and LDL-C in male participants with T2DM, for which the LDL-C was increased with BMI in the lean population, while LDL-C gradually tended to be flat or even decreased in the obese population. However, the Inverted U-shape between BMI and LDL-C was not found in female patients with T2DM.
Identifiants
pubmed: 37484947
doi: 10.3389/fendo.2023.1180012
pmc: PMC10360932
doi:
Substances chimiques
Cholesterol, LDL
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1180012Informations de copyright
Copyright © 2023 Li, Cao, Wang, Chai, Ke and Zhao.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Lancet. 2010 May 8;375(9726):1634-9
pubmed: 20452521
Front Endocrinol (Lausanne). 2022 Mar 30;13:780979
pubmed: 35432199
Obes Res. 2000 Sep;8(6):411-21
pubmed: 11011907
Arch Gerontol Geriatr. 2011 Mar-Apr;52(2):217-22
pubmed: 20417975
Nat Rev Cardiol. 2020 Mar;17(3):132-133
pubmed: 31853048
J Am Coll Nutr. 1997 Dec;16(6):578-83
pubmed: 9430086
Am J Clin Nutr. 1997 Oct;66(4):829-36
pubmed: 9322557
Atherosclerosis. 2010 Aug;211(2):353-60
pubmed: 20189175
JAMA Cardiol. 2021 Dec 1;6(12):1406-1413
pubmed: 34550307
Atherosclerosis. 2016 Oct;253:281-344
pubmed: 27594540
Clin Chim Acta. 2019 Jul;494:151-156
pubmed: 31002780
N Engl J Med. 2011 Mar 03;364(9):829-841
pubmed: 21366474
Front Cardiovasc Med. 2022 Feb 24;9:813208
pubmed: 35282373
Nutr Metab Cardiovasc Dis. 2007 Feb;17(2):125-39
pubmed: 17270403
Eur Heart J. 2015 Mar 1;36(9):539-50
pubmed: 24474739
Metabolism. 2004 Apr;53(4):495-9
pubmed: 15045698
Eur J Prev Cardiol. 2022 May 6;29(6):959-967
pubmed: 34669922
Arterioscler Thromb Vasc Biol. 2021 Nov;41(11):2708-2725
pubmed: 34551590
J Am Coll Cardiol. 2020 Sep 29;76(13):1507-1516
pubmed: 32972526
Maturitas. 1999 Dec 15;33(3):259-69
pubmed: 10656504
Eur J Prev Cardiol. 2022 Aug 5;29(10):1448-1459
pubmed: 35930503
Lipids Health Dis. 2021 Nov 14;20(1):162
pubmed: 34774059
Curr Vasc Pharmacol. 2012 Nov;10(6):684-6
pubmed: 23259553
Diabetes Care. 2018 Oct;41(10):2195-2201
pubmed: 30061315
J Am Coll Cardiol. 2015 Apr 21;65(15):1552-61
pubmed: 25770315
Obes Surg. 2011 Jan;21(1):42-7
pubmed: 20563664